Company news

Yoda Pharmaceuticals Inc. (TPEX:7829) news

Yoda Pharmaceuticals Inc. news releases on 6ix. Latest, Jul 28, 2026: Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial…

View Yoda Pharmaceuticals Inc. →

Press releases & updates

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

July 28, 2026